Tirzepatide

Description

Tirzepatide is a research peptide studied in laboratory settings for dual GIP and GLP-1 receptor activity, incretin signaling pathways, glucose metabolism research, and metabolic regulation models. Intended for laboratory and research use only.

Research Applications

• Dual GIP / GLP-1 Receptor Activity
• Metabolic Signaling
• Glucose-Metabolism Research
• Appetite-Regulation Models

Mechanism of Action

Tirzepatide is studied for its dual interaction with GIP and GLP-1 receptor pathways, where research explores metabolic signaling and glucose-metabolism models.

Product Specifications

• Active ingredient: Tirzepatide (LY3298176; synthetic lipidated peptide, 39 amino acids)
• Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular weight: ~4813.5 g/mol
• CAS No.: 2023788-19-2
• Purity: ≥99 % (HPLC)
• Form: Lyophilized powder

Size

• 10mg – 10mg per vial
• 20mg – 2 vials (10mg per vial)
• 100mg – 10 vials (10mg per vial)
• 200mg – 20 vials (10mg per vial)

Intended Use

This product is intended exclusively for laboratory and scientific research purposes. It is not intended for human consumption, medical use, diagnostic procedures, or veterinary applications.

Storage

Before Reconstitution

• Store in a cool, dry place.
• Protect from direct sunlight.
• Keep the vial tightly sealed.

After Reconstitution

• Store refrigerated at 2–8°C.
• Avoid repeated freeze-thaw cycles.
• Protect from contamination by following proper laboratory handling procedures.

Warnings

• For Research Use Only.
• Not for Human Consumption.
• Keep out of reach of children.
• Do not use if the vial or seal is damaged.
• Handle using appropriate laboratory procedures.
• Dispose of materials according to local laboratory regulations.

PRODUCT CLASSIFICATION: RESEARCH PRODUCT — NOT FOR HUMAN OR ANIMAL USE